Differential regulation of mitogen-activated protein kinase signaling pathways in human with different types of mitral valvular disease

Journal of Surgical Research

Volumn 181, Issue 1, 2013, Pages 49-59

  Chang, Chao ^a   Zhang, Chongjie ^b   Zhao, Xia ^c   Kuang, Xinglin ^b   Tang, Hong ^a   Xiao, Xijun ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Fibrosis; Mitogen activated protein kinase; Mitral valvular disease

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANGIOTENSIN II; CASPASE 3; COLLAGEN TYPE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C FOS;

ADULT; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; HEART ATRIUM APPENDAGE; HEART LEFT ATRIUM PRESSURE; HEART MUSCLE CELL; HEART VENTRICLE OVERLOAD; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MITRAL VALVE DISEASE; MITRAL VALVE REPLACEMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RNA ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; ANGIOTENSIN II; CASPASE 3; COLLAGEN TYPE I; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HEART VALVE DISEASES; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MITRAL VALVE; PHOSPHORYLATION;

EID: 84884212908     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.05.028     Document Type: Article

References (36)

1. J.P. Williams Postoperative management of the cardiac surgical patient 1996 Churchill Livingstone New York
2. J.S. Healey, A. Baranchuk, and E. Crystal Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis J Am Coll Cardiol 45 2005 1832
3. J. Xu, O.A. Carretero, and C.X. Lin Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction Am J Physiol Heart Circ Physiol 293 2007 H1900
4. C.S. Lin, and C.H. Pan Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation Cell Mol Life Sci 65 2008 1489
5. A. Goette, U. Lendeckel, and H.U. Klein Signal transduction systems and atrial fibrillation Cardiovasc Res 54 2002 247
6. A.J. Muslin MAPK signalling in cardiovascular health and disease: Molecular mechanisms and therapeutic targets Clin Sci (Lond) 115 2008 203
7. M. van Eickels, C. Grohe, and K. Lobbert Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts Naunyn Schmiedebergs Arch Pharmacol 359 1999 394
8. M. Ushio-Fukai, R.W. Alexander, and M. Akers p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy J Biol Chem 273 1998 15022
9. B.A. Rose, T. Force, and Y. Wang Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale Physiol Rev 90 2010 1507
10. M. Raman, W. Chen, and M.H. Cobb Differential regulation and properties of MAPKs Oncogene 26 2007 3100
11. T. Ravingerova, M. Barancik, and M. Strniskova Mitogen-activated protein kinases: A new therapeutic target in cardiac pathology Mol Cell Biochem 247 2003 127
12. D. Li, K. Shinagawa, and L. Pang Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure Circulation 104 2001 2608
13. A. Goette, T. Staack, and C. Rocken Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation J Am Coll Cardiol 35 2000 1669
14. M. Allessie, J. Ausma, and U. Schotten Electrical, contractile and structural remodeling during atrial fibrillation Cardiovasc Res 54 2002 230
15. S. Cardin, D. Li, and N. Thorin-Trescases Evolution of the atrial fibrillation substrate in experimental congestive heart failure: Angiotensin-dependent and -independent pathways Cardiovasc Res 60 2003 315
16. Y. Qian, J. Meng, and H. Tang Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases Europace 12 2010 371
17. W. Cheng, B. Li, and J. Kajstura Stretch-induced programmed myocyte cell death J Clin Invest 96 1995 2247
18. C. Ruwhof, and A. van der Laarse Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways Cardiovasc Res 47 2000 23
19. N. Hanna, S. Cardin, and T.K. Leung Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure Cardiovasc Res 63 2004 236
20. O.H. Bing, H.Q. Ngo, and D.E. Humphries Localization of alpha1(I) collagen mRNA in myocardium from the spontaneously hypertensive rat during the transition from compensated hypertrophy to failure J Mol Cell Cardiol 29 1997 2335
21. B. Swynghedauw Molecular mechanisms of myocardial remodeling Physiol Rev 79 1999 215
22. D.E. Dostal, and K.M. Baker The cardiac renin-angiotensin system: Conceptual, or a regulator of cardiac function? Circ Res 85 1999 643
23. J. Kajstura, E. Cigola, and A. Malhotra Angiotensin II induces apoptosis of adult ventricular myocytes in vitro J Mol Cell Cardiol 29 1997 859
24. J. Sadoshima, and S. Izumo Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: Potential involvement of an autocrine/paracrine mechanism EMBO J 12 1993 1681
25. H. Lal, S.K. Verma, and H.B. Golden Stretch-induced regulation of angiotensinogen gene expression in cardiac myocytes and fibroblasts: Opposing roles of JNK1/2 and p38alpha MAP kinases J Mol Cell Cardiol 45 2008 770
26. J. Sadoshima, Y. Xu, and H.S. Slayter Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro Cell 75 1993 977
27. M. Cargnello, and P.P. Roux Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases Microbiol Mol Biol Rev 75 2011 50
28. K. Ono, and J. Han The p38 signal transduction pathway: Activation and function Cell Signal 12 2000 1
29. M.S. Marber, B. Rose, and Y. Wang The p38 mitogen-activated protein kinase pathway - A potential target for intervention in infarction, hypertrophy, and heart failure J Mol Cell Cardiol 51 2011 485
30. K. Nishida, O. Yamaguchi, and S. Hirotani p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload Mol Cell Biol 24 2004 10611
31. D. Dingar, C. Merlen, and S. Grandy Effect of pressure overload-induced hypertrophy on the expression and localization of p38 MAP kinase isoforms in the mouse heart Cell Signal 22 2010 1634
32. J.E. Bishop Regulation of cardiovascular collagen deposition by mechanical forces Mol Med Today 4 1998 69
33. K.T. Weber Cardiac interstitium in health and disease: The fibrillar collagen network J Am Coll Cardiol 13 1989 1637
34. A. Goette, M. Arndt, and C. Rocken Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans Circulation 101 2000 2678
35. M. Arndt, U. Lendeckel, and C. Rocken Altered expression of ADAMs (a disintegrin and metalloproteinase) in fibrillating human atria Circulation 105 2002 720
36. B.J. Brundel, I.C. Van Gelder, and A.E. Tuinenburg Endothelin system in human persistent and paroxysmal atrial fibrillation J Cardiovasc Electrophysiol 12 2001 737